Actively Recruiting
Using Radiogenomics and MRI to Guide Treatment Decisions in Adults with Small Renal Tumors
Led by IRCCS San Raffaele · Updated on 2026-03-17
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying how to improve decision-making for treating renal cell carcinoma by using a combination of tumor biopsy analyses and advanced imaging techniques. This includes standard histology, immunohistochemistry, spatial transcriptomics, genomics, magnetic resonance imaging MRI, and radiomics. The study aims to identify markers that may predict how patients respond to systemic treatments or ablative therapies. The study involves observing patients with renal tumors who are candidates for surgery. Researchers will use multiparametric preoperative MRI and analyze tissue samples from tumor biopsies to gather detailed information. This observational study does not involve treatment assignment but focuses on collecting data to enhance understanding and guide future care decisions. Participants will undergo MRI scans before surgery and provide tumor biopsy samples for analysis. The main outcome measured is the accuracy of the preoperative MRI compared to the final pathology results after surgery, assessed at least one month post-operation. The study will monitor participants over time to evaluate imaging and biopsy markers and their potential to inform treatment choices.
CONDITIONS
Brief Title
Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform
Research Team
U
Umberto Capitanio
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here